Stryker Corporation Share Price

Equities

SYK

US8636671013

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 26/04/2024 BST 5-day change 1st Jan Change
335.6 USD -0.46% Intraday chart for Stryker Corporation +3.13% +12.07%
Sales 2024 * 22.17B 1,775B Sales 2025 * 23.83B 1,908B Capitalization 128B 10,216B
Net income 2024 * 3.88B 310B Net income 2025 * 4.4B 352B EV / Sales 2024 * 6.11 x
Net Debt 2024 * 7.75B 621B Net Debt 2025 * 5.35B 429B EV / Sales 2025 * 5.58 x
P/E ratio 2024 *
33.4 x
P/E ratio 2025 *
29.3 x
Employees 52,000
Yield 2024 *
0.95%
Yield 2025 *
1.03%
Free-Float 94.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.46%
1 week+3.13%
Current month-6.22%
1 month-4.22%
3 months+7.79%
6 months+29.79%
Current year+12.07%
More quotes
1 week
323.75
Extreme 323.75
342.60
1 month
323.75
Extreme 323.75
359.50
Current year
292.43
Extreme 292.43
361.41
1 year
249.98
Extreme 249.98
361.41
3 years
188.84
Extreme 188.84
361.41
5 years
124.54
Extreme 124.54
361.41
10 years
75.78
Extreme 75.78
361.41
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 24/04/11
Director of Finance/CFO 62 31/12/02
Chief Tech/Sci/R&D Officer - 31/12/14
Members of the board TitleAgeSince
Director/Board Member 80 31/12/73
Director/Board Member 65 01/05/18
Director/Board Member 89 31/01/77
More insiders
Date Price Change Volume
26/04/24 335.6 -0.46% 1,063,790
25/04/24 337.2 +0.09% 1,615,335
24/04/24 336.8 +0.58% 1,515,676
23/04/24 334.9 +2.21% 1,430,549
22/04/24 327.7 +0.69% 1,688,622

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
335.6 USD
Average target price
365.7 USD
Spread / Average Target
+8.96%
Consensus